Prümmer, Julia K.; Howard, Judith; Grandt, Lisa M.; Obrador de Aguilar, Rafael; Meneses, Felix; Peters, Laureen M. (2020). Hyperlipasemia in critically ill dogs with and without acute pancreatitis: Prevalence, underlying diseases, predictors, and outcome. Journal of veterinary internal medicine, 34(6), pp. 2319-2329. Wiley-Blackwell 10.1111/jvim.15902
|
Text
Pr_mmer_2020_Hyperlipasemia_critically_ill_dogs_JVIM.pdf - Published Version Available under License Creative Commons: Attribution-Noncommercial (CC-BY-NC). Download (2MB) | Preview |
Background: Hyperlipasemia is frequently reported in critically ill people without evidence of acute pancreatitis (AP), and has been associated with increased morbidity and mortality.
Hypothesis/Objectives: To evaluate the prevalence of hyperlipasemia at admission and development of hyperlipasemia during hospitalization in critically ill dogs, explore factors associated with hyperlipasemia, and evaluate association with outcome.
Animals: Critically ill, client owned dogs (n=1,360), presented onas emergencyies and admitted to the intensive care unit, which that had 1,2-o-dilauryl-rac-glycero-3-glutaric acid-(6’-methylresorufin) ester (DGGR) lipase activity measured within 24 hours of admission.
Methods: Retrospective cross-sectional study of clinical and laboratory records.
Results: The DGGR -lipase activity was increased >above 3×x the upper reference limit at admission in 216/1,360 (16%) dogs, of which 70/216 (32%) had a clinical diagnosis of AP. Other primary conditions associated with hyperlipasemia were renal, endocrine, and immune-mediated diseases, and upper airway obstruction. Predictors of hyperlipasemia at admission were prior glucocorticoid administration, vomiting and abdominal pain, increased age, plasma bilirubin and creatinine concentrations, and decreased hematocrit. Of dogs with repeat measurements, 78/345 (23%) had significantly increased lipase during hospitalization, of which 13/78 (17%) had a clinical diagnosis of AP. Other primary conditions associated with in-hospital hyperlipasemia were renal and immune-mediated disorders. Predictors of developing hyperlipasemia during hospitalization were hemodialysis events, increased plasma bilirubin and creatinine concentrations, and decreased hematocrit. Hyperlipasemia both at admission and during hospitalization was associated with longer hospitalization and higher mortality.
Conclusions and Clinical Importance: Significant DGGR-hyperlipasemia is frequent in critically ill dogs and is associated with a variety of nonpancreatic conditions and a negative outcome.
Actions (login required)
 |
Edit item |